Functional assays showed that overexpression of RRP9 promoted acute myeloid leukemia cell proliferation and resistance to the chidamide-cytarabine combination, whereas RRP9 knockdown impaired rRNA synthesis, reduced nucleolar size, and diminished protein production. This evidence concerns the gene RRP9 and acute myeloid leukemia.